Bard Associates Inc. Trims Stock Holdings in The Pennant Group, Inc. (NASDAQ:PNTG)

Bard Associates Inc. lessened its holdings in shares of The Pennant Group, Inc. (NASDAQ:PNTG) by 1.8% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 26,900 shares of the company’s stock after selling 500 shares during the quarter. Bard Associates Inc.’s holdings in The Pennant Group were worth $960,000 as of its most recent filing with the SEC.

A number of other large investors have also modified their holdings of PNTG. Mirae Asset Global Investments Co. Ltd. increased its holdings in shares of The Pennant Group by 101.4% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 22,908 shares of the company’s stock valued at $450,000 after acquiring an additional 11,536 shares during the period. Sei Investments Co. grew its position in The Pennant Group by 679.7% in the 1st quarter. Sei Investments Co. now owns 136,026 shares of the company’s stock valued at $2,670,000 after buying an additional 118,581 shares during the last quarter. State Board of Administration of Florida Retirement System acquired a new position in The Pennant Group in the 1st quarter valued at $279,000. Vanguard Group Inc. raised its position in The Pennant Group by 4.3% during the 1st quarter. Vanguard Group Inc. now owns 1,859,679 shares of the company’s stock worth $36,505,000 after buying an additional 77,052 shares during the last quarter. Finally, Acadian Asset Management LLC acquired a new stake in shares of The Pennant Group in the 1st quarter worth $218,000. Hedge funds and other institutional investors own 85.88% of the company’s stock.

The Pennant Group Price Performance

Shares of NASDAQ:PNTG opened at $31.90 on Friday. The Pennant Group, Inc. has a 12 month low of $12.65 and a 12 month high of $37.13. The firm has a market capitalization of $1.10 billion, a price-to-earnings ratio of 46.91, a price-to-earnings-growth ratio of 3.36 and a beta of 2.02. The business’s 50 day simple moving average is $33.79 and its 200-day simple moving average is $28.77. The company has a debt-to-equity ratio of 0.58, a current ratio of 1.12 and a quick ratio of 1.12.

Analysts Set New Price Targets

Several research firms recently issued reports on PNTG. Stephens reissued an “overweight” rating and set a $40.00 price target on shares of The Pennant Group in a report on Wednesday, October 9th. Royal Bank of Canada increased their target price on The Pennant Group from $26.00 to $38.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 23rd. Oppenheimer increased their price objective on The Pennant Group from $34.00 to $37.00 and gave the stock an “outperform” rating in a research report on Friday, November 8th. Finally, Truist Financial boosted their target price on shares of The Pennant Group from $34.00 to $38.00 and gave the stock a “hold” rating in a research report on Monday, October 7th.

About The Pennant Group

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.